Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 372

1.

Clinicians and Cognitive Bias: A Case of Frontotemporal Dementia Misdiagnosed as Conversion Disorder.

Braus BR, Rummans TA, Lapid MI, Morgan RJ, Sampson SM, Handler EM, Dimsdale JE.

Am J Psychiatry. 2019 Sep 1;176(9):690-693. doi: 10.1176/appi.ajp.2018.18050551. No abstract available.

PMID:
31474126
2.

A phase I trial of intraperitoneal nab-paclitaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity.

Cristea MC, Frankel P, Synold T, Rivkin S, Lim D, Chung V, Chao J, Wakabayashi M, Paz B, Han E, Lin P, Leong L, Hakim A, Carroll M, Prakash N, Dellinger T, Park M, Morgan RJ.

Cancer Chemother Pharmacol. 2019 Mar;83(3):589-598. doi: 10.1007/s00280-019-03767-9. Epub 2019 Jan 8.

PMID:
30623229
3.

Reality testing of the efficacy of tDCS on auditory hallucinations in schizophrenia.

Morgan RJ, Singh B.

Schizophr Res. 2018 Sep;199:454-455. doi: 10.1016/j.schres.2018.04.018. No abstract available.

PMID:
29764758
4.

Clozapine-induced cardiomyopathy and myocarditis monitoring: A systematic review.

Knoph KN, Morgan RJ 3rd, Palmer BA, Schak KM, Owen AC, Leloux MR, Patel M, Leung JG.

Schizophr Res. 2018 Sep;199:17-30. doi: 10.1016/j.schres.2018.03.006. Epub 2018 Mar 13.

PMID:
29548760
5.

Research Tracks During Psychiatry Residency Training.

Blacker CJ, Morgan RJ.

Acad Psychiatry. 2018 Oct;42(5):698-704. doi: 10.1007/s40596-018-0897-3. Epub 2018 Mar 8. No abstract available.

PMID:
29520584
6.

Treatment of Generalized Anxiety Disorder with Gabapentin.

Markota M, Morgan RJ.

Case Rep Psychiatry. 2017;2017:6045017. doi: 10.1155/2017/6045017. Epub 2017 Dec 14.

7.

The Electroencephalogram Speaks for the Patient: Identification and Treatment of Akinetic Mutism With Comorbid Delirium.

Foroughi M, Morgan RJ.

Psychosomatics. 2018 May - Jun;59(3):306-310. doi: 10.1016/j.psym.2017.11.004. Epub 2017 Nov 15. No abstract available.

PMID:
29249557
8.

Corrigendum to "Continuation phase intravenous ketamine in adults with treatment-resistant depression" [J. Affect. Disord. 206 (2016) 300-304].

Vande Voort JL, Morgan RJ, Kung S, Rasmussen KG, Rico J, Palmer BA, Schak KM, Tye SJ, Ritter MJ, Frye MA, Bobo WV.

J Affect Disord. 2018 Aug 15;236:313. doi: 10.1016/j.jad.2017.09.024. Epub 2017 Sep 27. No abstract available.

PMID:
28967437
9.

Characterization of Admission Types in Medically Hospitalized Patients Prescribed Clozapine.

Leung JG, Hasassri ME, Barreto JN, Nelson S, Morgan RJ 3rd.

Psychosomatics. 2017 Mar - Apr;58(2):164-172. doi: 10.1016/j.psym.2016.11.013. Epub 2016 Nov 18.

PMID:
28153339
10.

Surgical Management of Vulvar Cancer.

Dellinger TH, Hakim AA, Lee SJ, Wakabayashi MT, Morgan RJ, Han ES.

J Natl Compr Canc Netw. 2017 Jan;15(1):121-128. Review.

PMID:
28040722
11.

Continuation phase intravenous ketamine in adults with treatment-resistant depression.

Vande Voort JL, Morgan RJ, Kung S, Rasmussen KG, Rico J, Palmer BA, Schak KM, Tye SJ, Ritter MJ, Frye MA, Bobo WV.

J Affect Disord. 2016 Dec;206:300-304. doi: 10.1016/j.jad.2016.09.008. Epub 2016 Sep 12. Erratum in: J Affect Disord. 2018 Aug 15;236:313.

PMID:
27656788
12.

Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.

Morgan RJ Jr, Armstrong DK, Alvarez RD, Bakkum-Gamez JN, Behbakht K, Chen LM, Copeland L, Crispens MA, DeRosa M, Dorigo O, Gershenson DM, Gray HJ, Hakam A, Havrilesky LJ, Johnston C, Lele S, Martin L, Matulonis UA, O'Malley DM, Penson RT, Percac-Lima S, Pineda M, Plaxe SC, Powell MA, Ratner E, Remmenga SW, Rose PG, Sabbatini P, Santoso JT, Werner TL, Burns J, Hughes M.

J Natl Compr Canc Netw. 2016 Sep;14(9):1134-63.

PMID:
27587625
13.

Amelioration of non-motor dysfunctions after transplantation of human dopamine neurons in a model of Parkinson's disease.

Lelos MJ, Morgan RJ, Kelly CM, Torres EM, Rosser AE, Dunnett SB.

Exp Neurol. 2016 Apr;278:54-61. doi: 10.1016/j.expneurol.2016.02.003. Epub 2016 Feb 4.

14.

NCCN Oncology Research Program's Investigator Steering Committee and NCCN Best Practices Committee Molecular Profiling Surveys.

Kurzrock R, Colevas AD, Olszanski A, Akerley W, Arteaga CL, Carson WE 3rd, Clark JW, DiPersio JF, Ettinger DS, Morgan RJ Jr, Schwartzberg LS, Venook AP, Gocke CD, Tait J, Stewart FM.

J Natl Compr Canc Netw. 2015 Nov;13(11):1337-46.

PMID:
26553764
15.

Pharmacodynamics (PD) and pharmacokinetics (PK) of E7389 (eribulin, halichondrin B analog) during a phase I trial in patients with advanced solid tumors: a California Cancer Consortium trial.

Morgan RJ, Synold TW, Longmate JA, Quinn DI, Gandara D, Lenz HJ, Ruel C, Xi B, Lewis MD, Colevas AD, Doroshow J, Newman EM.

Cancer Chemother Pharmacol. 2015 Nov;76(5):897-907. doi: 10.1007/s00280-015-2868-7. Epub 2015 Sep 11.

16.

Quality improvement education for venous thromboembolism (VTE) prevention in cancer.

Leong L, Mendelsohn M, Saavedra C, Morgan RJ.

J Contin Educ Health Prof. 2015 Spring;35 Suppl 1:S29-30. doi: 10.1002/chp.21287. No abstract available.

PMID:
26115240
17.

Practicing what we preach!

Morgan RJ Jr.

J Natl Compr Canc Netw. 2015 Feb;13(2):123-4. No abstract available.

PMID:
25691602
18.

Escitalopram-Induced Progressive Cervical Dystonia.

Morgan RJ, Dolenc TJ.

Psychosomatics. 2015 Sep-Oct;56(5):572-5. doi: 10.1016/j.psym.2014.09.008. Epub 2014 Dec 5. No abstract available.

PMID:
25660435
19.

Randomized Trial of Oral Cyclophosphamide and Veliparib in High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers, or BRCA-Mutant Ovarian Cancer.

Kummar S, Oza AM, Fleming GF, Sullivan DM, Gandara DR, Naughton MJ, Villalona-Calero MA, Morgan RJ Jr, Szabo PM, Youn A, Chen AP, Ji J, Allen DE, Lih CJ, Mehaffey MG, Walsh WD, McGregor PM 3rd, Steinberg SM, Williams PM, Kinders RJ, Conley BA, Simon RM, Doroshow JH.

Clin Cancer Res. 2015 Apr 1;21(7):1574-82. doi: 10.1158/1078-0432.CCR-14-2565. Epub 2015 Jan 14.

20.

A phase I, pharmacokinetic, and pharmacodynamic evaluation of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine, administered with tetrahydrouridine.

Newman EM, Morgan RJ, Kummar S, Beumer JH, Blanchard MS, Ruel C, El-Khoueiry AB, Carroll MI, Hou JM, Li C, Lenz HJ, Eiseman JL, Doroshow JH.

Cancer Chemother Pharmacol. 2015 Mar;75(3):537-46. doi: 10.1007/s00280-014-2674-7. Epub 2015 Jan 8.

21.

NCCN Working Group report: designing clinical trials in the era of multiple biomarkers and targeted therapies.

Venook AP, Arcila ME, Benson AB 3rd, Berry DA, Camidge DR, Carlson RW, Choueiri TK, Guild V, Kalemkerian GP, Kurzrock R, Lovly CM, McKee AE, Morgan RJ, Olszanski AJ, Redman MW, Stearns V, McClure J, Birkeland ML.

J Natl Compr Canc Netw. 2014 Nov;12(11):1629-49.

22.
23.

Cytosolic H2O2 mediates hypertrophy, apoptosis, and decreased SERCA activity in mice with chronic hemodynamic overload.

Qin F, Siwik DA, Pimentel DR, Morgan RJ, Biolo A, Tu VH, Kang YJ, Cohen RA, Colucci WS.

Am J Physiol Heart Circ Physiol. 2014 May 15;306(10):H1453-63. doi: 10.1152/ajpheart.00084.2014. Epub 2014 Mar 14.

24.

Ovarian cancer, version 2.2013.

Morgan RJ Jr, Alvarez RD, Armstrong DK, Burger RA, Chen LM, Copeland L, Crispens MA, Gershenson DM, Gray HJ, Hakam A, Havrilesky LJ, Johnston C, Lele S, Martin L, Matulonis UA, O'Malley DM, Penson RT, Powell MA, Remmenga SW, Sabbatini P, Santoso JT, Schink JC, Teng N, Werner TL, Dwyer MA, Hughes M; National comprehensive cancer networks.

J Natl Compr Canc Netw. 2013 Oct 1;11(10):1199-209.

PMID:
24142821
25.

Ovarian cancer, version 3.2012.

Morgan RJ Jr, Alvarez RD, Armstrong DK, Burger RA, Castells M, Chen LM, Copeland L, Crispens MA, Gershenson D, Gray H, Hakam A, Havrilesky LJ, Johnston C, Lele S, Martin L, Matulonis UA, O'Malley DM, Penson RT, Remmenga SW, Sabbatini P, Santoso JT, Schilder RJ, Schink J, Teng N, Werner TL, Hughes M, Dwyer MA; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2012 Nov 1;10(11):1339-49.

PMID:
23138163
26.

Computer Modeling of Epilepsy.

Case MJ, Morgan RJ, Schneider CJ, Soltesz I.

In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV, editors. Jasper's Basic Mechanisms of the Epilepsies [Internet]. 4th edition. Bethesda (MD): National Center for Biotechnology Information (US); 2012.

27.

Thinking outside the box about screening for ovarian cancer: the nose knows!

Morgan RJ.

J Natl Compr Canc Netw. 2012 Jun 1;10(6):795-6. No abstract available.

PMID:
22679121
28.

Anaphylaxis to chlorhexidine-coated central venous catheters: a case series and review of the literature.

Guleri A, Kumar A, Morgan RJ, Hartley M, Roberts DH.

Surg Infect (Larchmt). 2012 Jun;13(3):171-4. doi: 10.1089/sur.2011.011. Epub 2012 May 8. Review.

PMID:
22568873
29.

A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium Study.

Chao J, Synold TW, Morgan RJ Jr, Kunos C, Longmate J, Lenz HJ, Lim D, Shibata S, Chung V, Stoller RG, Belani CP, Gandara DR, McNamara M, Gitlitz BJ, Lau DH, Ramalingam SS, Davies A, Espinoza-Delgado I, Newman EM, Yen Y.

Cancer Chemother Pharmacol. 2012 Mar;69(3):835-43. doi: 10.1007/s00280-011-1779-5. Epub 2011 Nov 22.

30.

Personalized cancer genetics training for personalized medicine: improving community-based healthcare through a genetically literate workforce.

Blazer KR, Macdonald DJ, Culver JO, Huizenga CR, Morgan RJ, Uman GC, Weitzel JN.

Genet Med. 2011 Sep;13(9):832-40. doi: 10.1097/GIM.0b013e31821882b7.

31.

Spontaneous passage of common bile duct stones in jaundiced patients.

Lefemine V, Morgan RJ.

Hepatobiliary Pancreat Dis Int. 2011 Apr;10(2):209-13.

PMID:
21459730
32.

Epithelial ovarian cancer.

Morgan RJ Jr, Alvarez RD, Armstrong DK, Boston B, Burger RA, Chen LM, Copeland L, Crispens MA, Gershenson D, Gray HJ, Grigsby PW, Hakam A, Havrilesky LJ, Johnston C, Lele S, Matulonis UA, O'Malley DM, Penson RT, Remmenga SW, Sabbatini P, Schilder RJ, Schink JC, Teng N, Werner TL; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2011 Jan;9(1):82-113. No abstract available.

PMID:
21233246
33.

Ovarian cancer guidelines: treatment progress and controversies.

Morgan RJ Jr.

J Natl Compr Canc Netw. 2011 Jan;9(1):4-5. No abstract available.

PMID:
21233240
34.

Cervical cancer.

Greer BE, Koh WJ, Abu-Rustum NR, Apte SM, Campos SM, Chan J, Cho KR, Copeland L, Crispens MA, Dupont N, Eifel PJ, Gaffney DK, Huh WK, Kapp DS, Lurain JR 3rd, Martin L, Morgan MA, Morgan RJ Jr, Mutch D, Remmenga SW, Reynolds RK, Small W Jr, Teng N, Valea FA; National Comprehensive Cancer Networks.

J Natl Compr Canc Netw. 2010 Dec;8(12):1388-416. No abstract available.

PMID:
21147903
35.

Phase II trial of bryostatin-1 in combination with cisplatin in patients with recurrent or persistent epithelial ovarian cancer: a California cancer consortium study.

Morgan RJ Jr, Leong L, Chow W, Gandara D, Frankel P, Garcia A, Lenz HJ, Doroshow JH.

Invest New Drugs. 2012 Apr;30(2):723-8. doi: 10.1007/s10637-010-9557-5. Epub 2010 Oct 9.

36.

Targeted agents in ovarian cancer.

Kristedja TS, Morgan RJ, Cristea M.

Womens Health (Lond). 2010 Sep;6(5):679-94. doi: 10.2217/whe.10.48. Review.

PMID:
20887168
37.

Superior pole sleeve fracture of the patella: a case report and review of the literature.

Gettys FK, Morgan RJ, Fleischli JE.

Am J Sports Med. 2010 Nov;38(11):2331-6. doi: 10.1177/0363546510374448. Epub 2010 Sep 1. Review. No abstract available.

PMID:
20810782
38.

Regulation of fast-spiking basket cell synapses by the chloride channel ClC-2.

Földy C, Lee SH, Morgan RJ, Soltesz I.

Nat Neurosci. 2010 Sep;13(9):1047-9. doi: 10.1038/nn.2609. Epub 2010 Aug 1.

39.

Evolving management of middle-third clavicle fractures in the National Football League.

Morgan RJ, Bankston LS Jr, Hoenig MP, Connor PM.

Am J Sports Med. 2010 Oct;38(10):2092-6. doi: 10.1177/0363546510372795. Epub 2010 Jul 7.

PMID:
20610772
40.

Ulnar collateral ligament reconstruction using the ToggleLoc with ZipLoop for ulnar side fixation.

Starman JS, Morgan RJ, Fleischli JE, D'Alessandro DF.

Orthopedics. 2010 May;33(5):312-6. doi: 10.3928/01477447-20100329-16. No abstract available.

PMID:
20507032
41.

A biomechanical evaluation of ulnar collateral ligament reconstruction using a novel technique for ulnar-sided fixation.

Morgan RJ, Starman JS, Habet NA, Peindl RD, Bankston LS Jr, D'Alessandro DD, Connor PM, Fleischli JE.

Am J Sports Med. 2010 Jul;38(7):1448-55. doi: 10.1177/0363546510363463. Epub 2010 May 4.

PMID:
20442324
42.

Practical considerations in ovarian cancer chemotherapy.

Cristea M, Han E, Salmon L, Morgan RJ.

Ther Adv Med Oncol. 2010 May;2(3):175-87. doi: 10.1177/1758834010361333.

43.

Phase I trial of fixed-dose rate gemcitabine in combination with bortezomib in advanced solid tumors.

Luu T, Chow W, Lim D, Koczywas M, Frankel P, Cristea M, Margolin K, Doroshow JH, Somlo G, Gaur S, Yen Y, Morgan RJ.

Anticancer Res. 2010 Jan;30(1):167-74.

PMID:
20150632
44.

A phase II study of sorafenib in advanced uterine carcinoma/carcinosarcoma: a trial of the Chicago, PMH, and California Phase II Consortia.

Nimeiri HS, Oza AM, Morgan RJ, Huo D, Elit L, Knost JA, Wade JL 3rd, Agamah E, Vokes EE, Fleming GF.

Gynecol Oncol. 2010 Apr;117(1):37-40. doi: 10.1016/j.ygyno.2010.01.013. Epub 2010 Feb 1.

45.

Plasma and cerebrospinal fluid pharmacokinetics of topotecan in a phase I trial of topotecan, tamoxifen, and carboplatin, in the treatment of recurrent or refractory brain or spinal cord tumors.

Morgan RJ, Synold T, Mamelak A, Lim D, Al-Kadhimi Z, Twardowski P, Leong L, Chow W, Margolin K, Shibata S, Somlo G, Yen Y, Frankel P, Doroshow JH.

Cancer Chemother Pharmacol. 2010 Oct;66(5):927-33. doi: 10.1007/s00280-010-1242-z. Epub 2010 Jan 28.

46.

Changing management of suspected appendicitis in the laparoscopic era.

Akbar F, Yousuf M, Morgan RJ, Maw A.

Ann R Coll Surg Engl. 2010 Jan;92(1):65-8. doi: 10.1308/003588410X12518836439920.

47.

Double Trouble? Potential for Hyperexcitability Following Both Channelopathic up- and Downregulation of I(h) in Epilepsy.

Dyhrfjeld-Johnsen J, Morgan RJ, Soltesz I.

Front Neurosci. 2009 May 1;3(1):25-33. doi: 10.3389/neuro.01.005.2009. eCollection 2009 May.

48.

NCCN task force: clinical utility of PET in a variety of tumor types.

Podoloff DA, Ball DW, Ben-Josef E, Benson AB 3rd, Cohen SJ, Coleman RE, Delbeke D, Ho M, Ilson DH, Kalemkerian GP, Lee RJ, Loeffler JS, Macapinlac HA, Morgan RJ Jr, Siegel BA, Singhal S, Tyler DS, Wong RJ.

J Natl Compr Canc Netw. 2009 Jun;7 Suppl 2:S1-26. Review.

PMID:
19555588
49.

Pursuing paradoxical proconvulsant prophylaxis for epileptogenesis.

Armstrong C, Morgan RJ, Soltesz I.

Epilepsia. 2009 Jul;50(7):1657-69. doi: 10.1111/j.1528-1167.2009.02173.x. Epub 2009 Jul 1. Review.

50.

Uterine Neoplasms. Clinical Practice Guidelines in Oncology.

Greer BE, Koh WJ, Abu-Rustum N, Bookman MA, Bristow RE, Campos SM, Cho KR, Copeland L, Crispens MA, Eifel PJ, Huh WK, Jaggernauth W, Kapp DS, Kavanagh JJ, Lurain JR 3rd, Morgan M, Morgan RJ, Powell CB, Remmenga SW, Reynolds RK, Alvarez Secord A, Small W Jr, Teng N.

J Natl Compr Canc Netw. 2009 May;7(5):498-531. Review. No abstract available.

PMID:
19460278

Supplemental Content

Loading ...
Support Center